(HealthDay)—This year's influenza vaccine is a fairly good match for the circulating viruses, according to research published in the Feb. 17 issue of the U.S. Centers for Disease Control and Prevention's Morbidity and Mortality ...
6
0
A vital race is on in laboratories across the globe to develop a vaccine for the Zika virus. However, even if a vaccine were available today, many of the world's poorest people would not be able to receive it due to political ...
0
0
The Advisory Committee on Immunization Practices (ACIP) released its 2017 Recommended Immunization Schedule for adults with major changes to the influenza, human papillomavirus (HPV), and meningococcal (MenB) vaccines. This ...
0
0
(Edmonton) A University of Alberta engineering researcher has developed a new way to treat common surgical masks so they are capable of trapping and killing airborne viruses. His research findings appear in the prestigious ...
684
0
(HealthDay)—For adults with solid cancer undergoing three-week cytotoxic chemotherapy cycles, antibody responses are comparable for influenza vaccination on day one and 11, according to a study published online Dec. 20 ...
0
0
(HealthDay)—The flu can be a serious threat to your health, but you can protect yourself by getting a flu shot, health experts say.
2
0
Universal vaccines that protect against multiple strains of influenza virus at once could offer key population-level benefits over conventional seasonal vaccines, according to a new study published in PLOS Computational Biology.
0
0
(HealthDay)—Among adults with diagnosed diabetes, vaccination coverage varies, with influenza vaccination more prevalent than pneumococcal or hepatitis B vaccination, according to a December data brief published by the ...
2
0
A team of researchers led by Yoshihiro Kawaoka, professor of pathobiological sciences at the University of Wisconsin-Madison School of Veterinary Medicine, has developed technology that could improve the production of vaccines ...
73
0
(Medical Xpress)—A team of researchers at Peking University has developed a new type of vaccine that they claim may allow for a new approach to generating live virus vaccines which could conceivably be adapted to any type ...
Subscribe to rss feed
